China Top 20 Companies 2017

  • ID: 4330577
  • Report
  • Region: China
  • 145 pages
  • Animal Pharm
1 of 4
China’s Animal Health Industry Has Grown Faster than the Rest of the Collective Global Animal Health Industry with a CAGR of 11.4% between 2007 and 2015

FEATURED COMPANIES

  • Bayer Animal Health China
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Elanco
  • IDEXX Laboratories
  • Merck/MSD Animal Health
  • MORE
The first of its kind published by the author, China Top 20 Companies report explores the sector’s rapid development and reveals how foreign firms are now well-placed to take advantage of opportunities.

Home to the world’s largest livestock industry, China has been the object of much fascination among global animal health companies. This report provides an overview of China’s current market and identifies trends and developments, market opportunities and challenges, and industry regulation in animal health.

With a CARGR of 11.4% between 2007 and 2015, China’s animal health industry has grown faster than the rest of the collective global animal health industry and is undergoing rapid transformation. However, with domestic animal health companies suffering from serious shortcomings and the sector remaining highly fragmented, new routes to market exist for foreign firms. Large-scale meat processors and livestock producers want high-quality animal health products. Chinese state-run and private animal health enterprises court commercial partnerships; and veterinary universities, institutes and associations are approaching counterparts abroad to collaborate on bilateral research programmes and industry events.

Yet challenges for foreign firms still abound. While negotiating China’s vast and complex regulatory frameworks is not straightforward, this report reveals how relationships have been successfully established.

Findings in the report include:
  • Top 20 domestic animal health companies in China
  • Top 10 international animal health companies in China
  • Sales of animal livestock vaccines in China
  • Sales of animal livestock veterinary medicines
  • Compulsory livestock vaccines and sales
  • Comprehensive livestock data
  • Pet ownership trends
  • Industry regulation - international perceptions and comparisons
  • Spending on research and development by Chinese animal health firms
  • Registered veterinary medicines (both APIs and manufactured medicines) and biologicals
  • Sales of traditional Chinese veterinary medicine
  • Chinese veterinary API manufacturing
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer Animal Health China
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Elanco
  • IDEXX Laboratories
  • Merck/MSD Animal Health
  • MORE
Executive summary

Chapter 1: China’s Economy & Political System
1.1 Introduction to China and its economy
1.2 Economic development
1.2.1 Economic risks
1.2.2 The state in the economy
1.2.3 The state in the animal health sector
1.2.4 Foreign direct investment in China
1.2.5 US dollar peg
1.2.6 Flaws in China’s Statistical Data
1.3 Political Overview
1.3.1 China’s political system
1.3.2 Political Risks
1.3.3 The Communist Party
1.3.4 Centre vs Provinces
1.3.5 China’s regulatory and judiciary
1.3.6 Corruption and Xi’s anti-corruption campaign
1.3.7 Food safety and environmental protection
1.3.8 Key Indicators

Chapter 2: Agriculture, Livestock and Pets
2.1 China’s agriculture development and policy
2.2 The livestock industry
2.3 Pork
2.3.1 Structural change
2.3.2 Market volatility
2.3.3 Long-term forecast
2.3.4 Swine diseases
2.4 Poultry
2.4.1 Structure
2.4.2 Tyson Foods
2.4.3 Marfrig and Chinwhiz
2.4.4 Cargill
2.4.5 Brasil Foods (BRF) and Dah Chong Hong
2.4.6 Perdue Farms and Dah Chong Hong
2.4.7 Fujian Shengnong and OSI
2.4.8 Shineway and Nippon Ham
2.4.9 Avian Flu
2.5 Dairy cattle
2.5.1 Structural change
2.6 Aquaculture
2.7 Pets

Chapter 3: Overview of China’s animal health market
3.1 Global and Chinese animal health industries compared
3.1.1 Sales by market segment
3.1.2 Slowdown
3.1.3 Growth forecasts
3.2 China and international trade of animal health products
3.2.1 Imports of veterinary biologicals
3.2.2 Imports of veterinary medicines
3.2.3 Import trends
3.3 China’s domestic animal health industry
3.3.1 China’s animal health enterprises
3.3.2 Financial overview of China’s animal health enterprises
3.3.3 Size of enterprises in veterinary medicines and veterinary biologicals
3.4 Veterinary biological firms
3.4.1 Overview
3.4.2 Enterprise size
3.4.3 Production capacity and capacity utilization rates
3.4.4 Numbers of new products registered, registration codes and usage
3.4.5 Popular veterinary products, 2015
3.4.6 Asset structure
3.4.7 Human capital
3.4.8 Overview of veterinary biological enterprises
3.4.9 Different structures of veterinary biological enterprise’ financial performance
3.5 Industry concentration
3.5.1 Industry concentration in poultry sector
3.5.2 Industry concentration in swine sector
3.5.3 Industry concentration in cattle sector
3.5.4 Comparison of sales of veterinary biological enterprise according to size
3.6 Research overview
3.6.1 New veterinary biologicals
3.6.2 Investment in research
3.6.3 Workforce engaged in research
3.6.4 Research methods
3.6.5 Research investment focus
3.6.6 Research investment methods
3.7 Veterinary biological sales overview
3.7.1 Market overview
3.7.2 Sales of veterinary biologicals for poultry
3.7.3 Sales of veterinary biologicals for swine
3.7.4 Cattle, sheep veterinary biologicals

Chapter 4: Compulsory vaccines
4.1 Market overview
4.1.1 Compulsory poultry vaccines
4.1.2 Compulsory swine vaccines
4.1.3 Compulsory cattle and ruminant vaccines
4.2 Other veterinary biologicals
4.2.1 Overview
4.2.2 Main non-compulsory vaccine product sales
4.3 Veterinary medicines and traditional Chinese veterinary medicines
4.3.1 Number of enterprises
4.3.2 Structure of veterinary medicine enterprises

Chapter 5: Economic overview
5.1 Veterinary medicine production value
5.2 Sales of veterinary medicine
5.2.1 Veterinary medicine enterprises’ rate of return on assets
5.3 Research overview
5.3.1 Research results
5.3.2 Research investment
5.3.3 Researchers
5.4 Veterinary API enterprises
5.4.1 Production capacity and capacity utilization rates of veterinary APIs
5.4.2 Economic overview
5.4.3 API registrations and utilization
5.4.4 Overview
5.4.5 Main API products
Antibiotic veterinary APIs
5.4.6 Sales overview
Overview
5.4.7 Production and sales trends by API category
5.4.8 Sales of main API products
5.5 Industry concentration
5.5.1 Overall industry concentration
5.5.2 Enterprise categories by sales
5.5.3 Veterinary medicines
5.5.4 Production capacity and capacity utilization
5.5.5 Economic overview
5.5.6 Registered veterinary medicine products
5.5.7 Main veterinary medicine products
5.5.8 Overall concentration rate

Chapter 6: Chinese veterinary medicine

Chapter 7: Exports
7.1 API exports

Chapter 8: Overview of top 13 Chinese market-listed animal health companies
8.1.1 Overview of 2014
8.1.2 Overview of 2015
8.2 China Animal Husbandry Group (?????(??)???)
8.2.1 Foreign partnerships
8.2.2 Subsidiaries
8.2.3 Analysis: SOEs at risk or retrenching?
8.3 China Animal Husbandry Industry Corporation Ltd. (CAHIC)
8.3.1 Veterinary sales
8.3.2 Foreign cooperation
8.3.3 Prospects
8.4 Jinyu Bio-Technology Co. Ltd. (Jinyu Baoling Biological Pharmaceutical)
8.4.1 Production facilities
8.4.2 Foreign partnerships
8.4.3 Research
8.4.4 Veterinary sales
8.4.5 Prospects
8.5 Tianjin Ringpu Biotechnology Co. Ltd.
8.5.1 Products, sales and regional focus
8.6 Xinjiang Tecon Animal Husbandry Bio-Technologu Co., Ltd (TECON)
8.6.1 Finances
8.7 Guangdong Wens Dahuanong Biotechnology Co. Ltd.
8.7.1 Finances
8.7.2 Analysis: Wens Foodstuff Group takeover
8.8 Shandong Lukang
8.8.1 Finances
8.9 Pulike Biological Engineering
8.9.1 Finances
8.10 Zhejiang Shenghua Biok Biology Co. Ltd. (Qingdao Yibang Bioengineering Co., Ltd)
8.10.1 Finances
8.11 Beijing Dabeinong Technology Group
8.12 China Animal Healthcare Ltd.
8.12.1 Controversy
8.13 Other important market listed and non-listed Chinese animal health companies

Chapter 9: Top International animal health companies
9.1 Zoetis
9.1.1 Financials
9.1.2 Prospects
9.1.3 Key quotes
9.2 Merck/MSD Animal Health
9.2.1 Products
9.2.2 Financials and performance
9.3 Merial
9.3.1 Poultry vaccine portfolio development
9.3.2 Veterinary products for swine
9.3.3 Companion animal products
9.3.4 R&D
9.3.5 Financials
9.3.6 Prospects
9.4 Elanco
9.4.1 Relationship with China Animal Healthcare
9.5 Bayer Animal Health China
9.5.1 Products
9.5.2 Performance
9.6 Boehringer Ingelheim
9.6.1 Products
9.6.2 Financials
9.6.3 Strategy
9.7 IDEXX Laboratories
9.8 Virbac
9.9 Ceva Santé Animale
9.10 Other foreign firms
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer Animal Health China
  • Beijing Dabeinong Technology Group
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • China Animal Healthcare Ltd.
  • China Animal Husbandry Group
  • China Animal Husbandry Industry Corporation Ltd. (CAHIC)
  • Elanco
  • Guangdong Wens Dahuanong Biotechnology Co. Ltd.
  • IDEXX Laboratories
  • Jinyu Bio-Technology Co. Ltd. (Jinyu Baoling Biological Pharmaceutical)
  • Merck/MSD Animal Health
  • Merial
  • Pulike Biological Engineering
  • Shandong Lukang
  • Tianjin Ringpu Biotechnology Co. Ltd.
  • Virbac
  • Xinjiang Tecon Animal Husbandry Bio-Technologu Co., Ltd (TECON)
  • Zhejiang Shenghua Biok Biology Co. Ltd. (Qingdao Yibang Bioengineering Co., Ltd)
  • Zoetis
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll